Earlier this summer, the FDA required the manufacturer of olmesartan medoxomil, sold as Benicar, to add another warning to the blood pressure medication label. The warning comes after some people have been injured by the drug and have suffered unpleasant side effects and hospitalizations.
Why a New Warning for Benicar?
The new warning comes after Mayo Clinic researchers found a connection between the drug and serious side effects experienced by some users of the drug. Specifically, researchers found that some patients were experiencing symptoms such as:
- Severe and chronic diarrhea. The patients included in the Mayo study had diarrhea for an average of 19 months.
- Substantial weight loss. The patients gained approximately 27 pounds when going off of Benicar.
The condition is known as sprue-like enteropathy and can mimic the symptoms of celiac disease, though the patients do not have celiac disease. Chronic diarrhea and significant weight loss can substantially affect a person’s quality of life and, for some patients, may endanger their lives.
In October 2012, a doctor told the American College of Gastroenterology meeting that she believed the known cases of sprue-like enteropathy linked to Benicar to be “the tip of the iceberg.”
Call An Experienced Attorney If You’ve Been Injured by Benicar
If you have suffered a side effect from the blood pressure medication known as olmesartan medoxomil or Benicar, then we encourage you to find out more about your rights. You may be able to join with others who have suffered similar serious side effects to file a class action lawsuit against the maker of Benicar.
For more information about protecting your legal rights and possible financial recovery, we encourage you to contact an pharmaceutical class action attorney today via this website or by calling 309-862-4800 or 866-532-4800. We would be pleased to provide you with more information so that you can make an informed decision about your future.